Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123654487 | 12365448 | 7 | F | 20151112 | 20160906 | 20160512 | 20160921 | EXP | JP-FRI-1000083337 | FOREST | 82.63 | YR | F | Y | 51.00000 | KG | 20160921 | OT | DK | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123654487 | 12365448 | 1 | PS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG | Y | 21323 | 10 | MG | TABLET | QD | |||||
123654487 | 12365448 | 2 | SS | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Oral | 20 MG | Y | 0 | 20 | MG | QD | ||||||
123654487 | 12365448 | 3 | SS | MYSLEE | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG | Y | 0 | 10 | MG | QD | ||||||
123654487 | 12365448 | 4 | SS | DEPAS | ETIZOLAM | 1 | Oral | 0.5 MG | Y | 0 | .5 | MG | QD | ||||||
123654487 | 12365448 | 5 | C | KAKKONTO | HERBALS | 1 | Oral | 0 | 1 | DF | |||||||||
123654487 | 12365448 | 6 | C | CALONAL | ACETAMINOPHEN | 1 | Oral | 0 | 300 | MG | |||||||||
123654487 | 12365448 | 7 | C | MOHRUS TAPE | KETOPROFEN | 1 | Transdermal | 0 | |||||||||||
123654487 | 12365448 | 8 | C | NEUROTROPIN | NEUROTROPIN | 1 | Intravenous (not otherwise specified) | UNIT DOSE: 3.6 UT | 0 | ||||||||||
123654487 | 12365448 | 9 | C | CLARITIN | LORATADINE | 1 | Oral | 0 | 10 | MG | |||||||||
123654487 | 12365448 | 10 | C | YOKUKANSAN | HERBALS | 1 | Oral | 0 | 1 | DF | |||||||||
123654487 | 12365448 | 11 | C | Meilax | ETHYL LOFLAZEPATE | 1 | Oral | 0 | 1 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123654487 | 12365448 | 1 | Depression |
123654487 | 12365448 | 2 | Hypertension |
123654487 | 12365448 | 3 | Insomnia |
123654487 | 12365448 | 4 | Insomnia |
123654487 | 12365448 | 5 | Musculoskeletal stiffness |
123654487 | 12365448 | 6 | Headache |
123654487 | 12365448 | 7 | Pain |
123654487 | 12365448 | 8 | Pain |
123654487 | 12365448 | 9 | Product used for unknown indication |
123654487 | 12365448 | 10 | Product used for unknown indication |
123654487 | 12365448 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123654487 | 12365448 | LT |
123654487 | 12365448 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123654487 | 12365448 | Electrocardiogram QT prolonged | |
123654487 | 12365448 | Ventricular fibrillation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123654487 | 12365448 | 1 | 20131101 | 20151112 | 0 | |
123654487 | 12365448 | 2 | 20130924 | 20151112 | 0 | |
123654487 | 12365448 | 3 | 20151111 | 0 | ||
123654487 | 12365448 | 4 | 20151111 | 0 | ||
123654487 | 12365448 | 5 | 20150807 | 0 | ||
123654487 | 12365448 | 8 | 20150421 | 0 | ||
123654487 | 12365448 | 9 | 20130513 | 20151114 | 0 | |
123654487 | 12365448 | 11 | 20131101 | 20131114 | 0 |